CAS 50-21-5

2-hydroxypropanoic acid

Codes：PANO-009

Application context (from source-drug indications)

多发性骨髓瘤乳酸帕比司他胶质瘤乳酸帕比司他弥漫性内源性庞汀胶质瘤乳酸帕比司他弥漫性中线胶质瘤乳酸帕比司他骨髓增生异常综合征乳酸帕比司他急性髓细胞样白血病乳酸帕比司他

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
乳酸帕比司他Panobinostat Lactate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

乳酸帕比司他优化路线steps: 5total yield: /

2-(2-methyl-1H-indol-3-yl)ethan-1-amine→methyl (E)-3-(4-formylphenyl)acrylate→4-bromobenzaldehyde→methyl acrylate→methyl (E)-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylate hydrochloride→2-hydroxypropanoic acid→phenylhydrazine→5-chloropentan-2-one

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.